RenovoRx, Inc.
RNXTDrugs in Pipeline
11
Phase 3 Programs
3
Upcoming Catalysts
2
Next Catalyst
Aug 12, 2026
8dMarket Overview
Stock performance and key metrics
2 upcoming, 0 past
RNXT Earnings Report
EPS Est: $-0.08 | FQ end 2026-06
1 more catalyst beyond 14 days
Start a 48-hour free trial to see all upcoming catalysts
How RNXT's past catalysts played out
Juvista (avotermin)
Cicatrix
Gemcitabine
Locally Advanced Pancreatic Cancer
estradiol (Zesteem)
Burn
Avotermin (Juvista)
Cicatrix
Intradermal avotermin
Cicatrix
Mannose-6-Phosphate (Juvidex)
Wound
Zesteem
Cicatrix
Avotermin (RN1001)
Cicatrix
Prevascar
Cicatrix
Juvidex
Cicatrix
Avotermin
Cicatrix
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Juvista (avotermin) | Phase 3 | Cicatrix | - | - |
Gemcitabine | Phase 3 | Locally Advanced Pancreatic Cancer | - | - |
estradiol (Zesteem) | Phase 3 | Burn | - | - |
Avotermin (Juvista) | Phase 2 | Cicatrix | - | - |
Intradermal avotermin | Phase 2 | Cicatrix | - | - |
Mannose-6-Phosphate (Juvidex) | Phase 2 | Wound | - | - |
Zesteem | Phase 2 | Cicatrix | - | - |
Avotermin (RN1001) | Phase 2 | Cicatrix | - | - |
Prevascar | Phase 2 | Cicatrix | - | - |
Juvidex | Phase 2 | Cicatrix | - | - |
Avotermin | Phase 2 | Cicatrix | - | - |
Full breakdown — the signals behind the verdict
Frequently asked questions
What is in RenovoRx, Inc.'s drug pipeline?→
CatalystAlert tracks 11 drug candidates in RenovoRx, Inc.'s (RNXT) pipeline across Phase 3, Phase 2. Its lead program is Juvista (avotermin) (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is RenovoRx, Inc.'s next FDA catalyst?→
RenovoRx, Inc.'s (RNXT) next tracked catalyst is a Earnings expected August 12, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track RNXT biotech catalysts?→
Add RNXT to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow RenovoRx, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.